BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Policy

  Novartis AG to Cough Up $390 Million to Settle U.S. Kickback Case

  October 27, 2015

   · 

  1 min read
• Drug Development

  Threshold Pharmaceuticals, Inc. Announces Preclinical Data Presentations On Tarloxotinib At The 2015 AACR-NCI-EORTC Meeting

  October 27, 2015

   · 

  8 min read
• Drug Development

  Amgen, Cytokinetics’s Heart Failure Drug Succeeds in Phase II Study

  October 27, 2015

   · 

  18 min read
• Deals

  Endologix Ponies Up $211 Million for TriVascular Tech

  October 27, 2015

   · 

  10 min read
• Circassia Business Update

  October 27, 2015

   · 

  6 min read
• Drug Development

  Symic Biomedical Advances First Product Candidate, SB-030, Into Clinical Development With Treatment Of First Patient In SHIELD Trial

  October 27, 2015

   · 

  3 min read
• Genetown

  Pope Francis Accepts Donation Of Terason uSmart 3200T Ultrasound System For Vatican

  October 27, 2015

   · 

  2 min read
• Drug Development

  GlaxoSmithKline’s Heart Drug Losmapimod Flunks Phase III Trial

  October 27, 2015

   · 

  1 min read
• Drug Development

  GlaxoSmithKline’s Shingles Vaccine Demonstrates 90% Efficacy in Pivotal Phase III Study

  October 27, 2015

   · 

  4 min read
• Drug Development

  Shire Jumps on Phase III Trial News for Dry Eye Treatment

  October 27, 2015

   · 

  11 min read